Stada Arzneimittel News
Most Popular Stada Arzneimittel Story
Teva comes out on top with $5B Ratiopharm bid
And the winner is... Teva. This morning, the generics giant announced that it was buying Ratiopharm for just under $5 billion, beating out Pfizer and Actavis for the German company. Ratiopharm is Read more...
Latest Headlines
- October 28, 2011
- October 4, 2011
- September 19, 2011
- September 29, 2010
- March 30, 2010
- March 19, 2010
- March 18, 2010
- March 9, 2010
- August 15, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
